The global immunotherapy drugs market is witnessing remarkable growth as demand for advanced and targeted treatment options surges across oncology, autoimmune diseases, and infectious diseases. Immunotherapy, which harnesses the body’s immune system to combat various illnesses, has emerged as a game-changing approach in modern medicine. Driven by a growing prevalence of chronic...

The global immunotherapy drugs market is witnessing remarkable growth as demand for advanced and targeted treatment options surges across oncology, autoimmune diseases, and infectious diseases. Immunotherapy, which harnesses the body’s immune system to combat various illnesses, has emerged as a game-changing approach in modern medicine. Driven by a growing prevalence of chronic...

According to a new report by Polaris Market Research, the global immunotherapy drugs market was valued at USD 327.74 billion in 2025 and is projected to reach USD 1,152.03 billion by 2034, expanding at a CAGR of 15.0% over the forecast period. Growth is underpinned by rising cancer and autoimmune disease prevalence, expanding CAR-T and checkpoint-inhibitor pipelines, and...

A new market analysis highlights the consistent expansion anticipated in the global Immunotherapy Drugs Market. Valued at USD 260.12 billion in 2024, the market is projected to grow from USD 273.59 billion in 2025 to a substantial USD 409.89 billion by 2032, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.95% during the forecast period. This steady growth is primarily driven by...

A new market analysis highlights the consistent expansion anticipated in the global Immunotherapy Drugs Market. Valued at USD 260.12 billion in 2024, the market is projected to grow from USD 273.59 billion in 2025 to a substantial USD 409.89 billion by 2032, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.95% during the forecast period. This steady growth is primarily driven by...

Multiple Myeloma Therapeutics Market Growing at 6.1% CAGR According to Straits Research, the global Multiple Myeloma Therapeutics Market was valued at USD 23.27 Billion in 2021 and is projected to grow from USD XX Billion in 2022 to USD 39.65 Billion by 2030, reflecting a CAGR of 6.1% over the forecast...